Sathyapalan, Thozhukat <br/><br/>
Endocannabinoid receptor blockade increases hepatocyte growth factor and reduces insulin levels in obese women with polycystic ovary syndrome.  [electronic resource] 

 -  Clinical endocrinology  Oct 2016 
 - 671-3 p.  digital 
<br/><br/> Publication Type: Letter; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1365-2265 
<br/><br/><label>Standard No.: </label>10.1111/cen.13120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Body Mass Index<br/>Cannabinoid Receptor Antagonists--therapeutic use<br/>Cytokines--blood<br/>Female<br/>Hepatocyte Growth Factor--blood<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin--therapeutic use<br/>Insulin Resistance<br/>Metformin--therapeutic use<br/>Non-alcoholic Fatty Liver Disease--blood<br/>Obesity--blood<br/>Piperidines--therapeutic use<br/>Polycystic Ovary Syndrome--blood<br/>Pyrazoles--therapeutic use<br/>Rimonabant